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CASE REPORT
Maggot debridement therapy with a direct dressing can cause compression
injuries in patients with chronic limb ischemia
Akio Nishijimaa, Naoto Yamamotoa, Ryuichi Yoshidaa, Satoshi Yanagibayashia, Megumi Takikawaa,
Rie Hayasakaa, Eri Maruyamaa, Junko Nishijimaa and Mitsuru Sekidob
aDepartment of Plastic and Reconstructive Surgery, New Tokyo Hospital, Matsudo, Chiba, Japan; bDepartment of Plastic and
Reconstructive Surgery, University of Tsukuba, Tsukuba, Ibaraki, Japan
ABSTRACT
While there are no reports regarding dressing-associated iatrogenic skin ulcer as an adverse
event of maggot debridement therapy (MDT), MDT is clinically used on patients with critical
limb ischaemia with dermal fragility. Herein we report causes and counter measures for a case
of iatrogenic skin ulcer induced by MDT dressing.
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Introduction
Maggot debridement therapy (MDT) dates back to the
ancient Mayans and as a Burmese folk remedy [1]. The
first scientific report was published in 1931 by William
Baer who performed MDT for chronic osteomyelitis [2].
MDT gradually fell into disuse due to the development
of antibiotics and improved surgical techniques;
however, it started to draw renewed attention as a
result of the increasing need of intractable ulcer treat-
ment associated with diabetes, arterial sclerosis, as
well as the appearance of multiple-drug resistant
bacteria.
One caution when applying dressing for MDT is to
prevent the escape of maggots. Two methods for
appropriately positioning the maggots are the direct
and indirect (using bags containing maggots) meth-
ods [3]. We conducted MDT on a patient with critical
limb ischaemia (CLI) for the purpose of wound-bed
preparation (WBP) following Chopart disarticulation.
However, a pressure ulcer developed during the treat-
ment period due to compression of the skin by the
dressing material, resulting in necrosis of the entire
skin layer. Herein, we report causes and measures for
iatrogenic skin ulcer during maggot debridement ther-
apy for a CLI patient.
Case report
A 64-year-old man complained of a low temperature
burn of the left ankle in January 2015. He had a
clinical history of chronic renal failure (undergoing
dialysis), cardiac failure, angina, diabetes, chronic
obstructive pulmonary disease, hypertension and
hyperlipidaemia.
In March 2016, distal bypass surgery was conducted
for a lesion in the arterial trifurcation of the left lower
limb, using the right great saphenous vein for the pos-
terior tibial artery in the range between the popliteal
artery and the ankle, followed by Chopart disarticula-
tion. The amputated surface was left as an open
wound, to permit cleansing, application of ointment
and spray of basic fibroblast growth factor (bFGF)
(Fiblast SprayVR , Kaken Pharmaceutical Co., Tokyo,
Japan) depending on the condition of the lesion.
However, the wound resisted healing, with yellowish
necrotic tissue and local infection noted on the wound
surface. As the patient refused to undergo major
amputation, MDT was initiated from July 2016, after
the determination that limb salvage by conventional
treatment was ineffective.
Laboratory test results before the onset of MDT
were as follows: left ankle brachial index (ABI): 0.63;
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skin perfusion pressure (SPP) of the dorsum of the left
foot: 26mmHg, SPP of the left sole: 30mmHg; C-react-
ive protein: 9.48mg/dL; white blood cell count:
7700/lL. Wound culture detected Enterocccus faecalis
and Escherichia coli.
Dressing method at the first hospitalisation:
maggot confinement dressings
1. The wound was cleansed with tap water, and bio-
films and ointment were removed from the
wound surface. Hydrocolloid dressing material
(Duo-activeVR , ConvaTec, Inc.) was applied to fit the
shape of the lesion for prevention of maceration
and for formation of an embankment for the
wound periphery.
2. An acrylic resin adhesive tape (Taketora Co.,
Yokohama, Japan) was applied around the wound
to fill the gap between the periphery and hydro-
colloid material (Figure 1(a)).
3. Second-instar larvae were placed on the wound
surface in the amount of 10 larvae/1 cm2, and cov-
ered with a meshed nylon net-sheet (Figure 1(b)).
Aseptic larvae were purchased from the Japan
Maggot Company, for which sterility was proved
by the fungus body carrier test.
4. Double stockings were applied, and then covered
by a paper diaper to absorb exudative fluid.
Using a 48-h duration period as one session of MDT,
two sessions were performed with the same procedure
for treatment of the left foot necrosis (Figure 2(a)).
At that time, the patient received no restrictions
regarding his lower limb movements, including bear-
ing load. After the second session of MDT, dermal
necrosis occurred in the dorsum of the ankle, accom-
panied by pain (Figure 2(b)), resulting in necrosis of
the entire skin layer and necessitating debridement of
the lesion (Figure 2(c)). Such dermal necrosis was not
seen in the medial or lateral portions of the ankle,
Achilles tendon or sole.
After the two MDT sessions, infection deteriorated,
showing CRP of 20.16mg/dL and WBC count of
6390/lL; thus, administration of Tazobactam/
Piperacillin was started at 9 g/day for 16 days. At 16
days of this administration, the condition improved,
showing CRP of 2.85mg/dL and WBC count of
3860/lL. The patient was discharged from hospital
24 days after the onset of MDT, and followed up with
outpatient consultations.
At 5 months after debridement, granulation forma-
tion was observed, though wound-bed preparation
(WBP) was necessary. Therefore, one additional session
of MDT was done, applying 10 maggots/cm2 for 24 h.
At that time, the surrounding intact skin was protected
by a spray coating agent (BravaVR ) and an ultra-thin
film dressing (Perme-RollVR , Nitoms, Inc., Tokyo Japan)
(Figure 2(d)). The necrotic wound tissues were then
removed by MDT with favourable granulation forma-
tion (Figure 2(e)). Skin graft of the entire skin layer
was performed in January 2017 (Figure 2(f)).
The grafted skin was completely taken, and epitheliza-
tion was observed 1 month later (Figure 2(g)).
Discussion
Generally, two methods are known for applying mag-
gots to wounds: directly or indirectly. The direct mag-
got application method is generally done either by
Figure 1. Confinement dressing for maggot debridement therapy. (a) Acrylic adhesive tape (arrow) was applied around the wound
to fill the gap between the periphery and hydrocolloid material. The tape extends to the ankle joint. The dotted line shows the
border at the portion where hydrocolloid material is pasted. (b) After placing second-instar larvae, a meshed nylon net-sheet was
used to cover the site.
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stocking or peripheral confinement. Jukema et al. pre-
sented a flow chart for the selection of dressing
method most suited to the location of the wound and
the amount of necrotic tissue [3]. For our patient, we
selected the direct method by peripheral confinement
with dressings because of: (1) the purpose of expedit-
ing WBP, (2) the relative ease of dressing a flat wound
surface and (3) the fact that the patient’s pain was
well-controlled.
Special attention is given toward minimising pres-
sure to the skin during dressing; however, in the pre-
sent CLI case, iatrogenic pressure ulceration occurred
due to the excessive dressing pressure to prevent the
escape of maggots. Three causes are considered for
the iatrogenic pressure ulcer. First, increased skin pres-
sure associated with excessive load when the ankle
was flexed, or due to oedema that occurred when the
foot was relaxed to the lower position (Figure 3). One
of the benefits of MDT is almost no restriction for
patients while resting after application of the dressing.
However, when the dressing material covers the ankle,
such as with our patient, the effect of bending or
occurrence of oedema should be taken into account,
as it may raise skin pressure at the dorsal flexion.
Second, the skin of the dorsum of the foot remained
fragile, which is a dominant region for the anterior tib-
ial artery. In our patient, post-operative angiography
indicated less blood flow to the dorsum of the foot. In
fact, a skin colour change appeared in the dorsum of
the ankle and gradually extended to the distal por-
tions (Figure 2(b,c)). Third, infection of the wound
worsened in our patient. Generally, maggots provide a
Figure 2. Treatment course of the wound. (a) Before maggot therapy. (b) After two sessions, necrosis of the skin was observed at
the dorsal side of the ankle. (c) Day 7 of necrosis site after debridement by the bedside. The necrosis extended to the entire ankle.
(d) Five months after debridement. Granulation formation was seen, so that the maggot therapy was planned to the yellowish
necrosis lesion on the surface. Before dressing, spray of a film forming agent and pasting of a film were done on the normal skin
(arrow). (e) After one session of maggot therapy. Marked reduction of necrotic tissues and favourable granulation formation were
seen. Peripheral normal skin was intact. (f) Skin graft was performed. (g) One month after operation. Complete take of the graft
was observed.
Figure 3. Illustration of compression on the skin after dressing the ankle. (a) Dressing is made on the dorsal side at rest position.
(b) Dressing material is compressing at flexion position (arrow).
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bactericidal action for both the inside and outside of
the body. In particular, antibacterial peptide contained
in the secretions of maggots is considered effective for
suppressing Gram-positive bacterium such as
Methicillin-resistant Staphylococcus aureus (MRSA) [4].
However, there is a lack of efficacy against Gram-nega-
tive bacterium [5], thus Escherichia coli detected in the
wound culture of our patient was not affected by
MDT. Negative pressure wound therapy is beneficial
after the infection is stopped; however, we did not use
it because of the concern about recurrence of infec-
tion in enclosed wound environment in our case.
At the second hospitalisation, we could prevent
damage of the skin by using a coating agent (BravaVR )
to the peripheral normal skin, covering the site with
an ultra-thin film dressing (Perme-RollVR ) at the time of
MDT (Figure 2(d,e)). To ensure a safer treatment, per-
haps the indirect MDT method should have been
used. However, we chose the direct MDT method with
careful gently handling the skin, because the patient
desired to shorten the treatment period as much as
possible.
Angioplasty is no doubt the highest priority in the
treatment of CLI patients. Thus, after reconstructing
vascular flow in the limb, appropriate treatments are
undertaken, such as debridement, amputation or
wound closure. However, successful WBP may not be
achieved in some CLI patients, even after attempting
angioplasty management. Adjuvant treatment meth-
ods other than MDT include hyperbaric oxygen ther-
apy [6], cell therapy [7], gene therapy (intravascular
growth factor) [8] and LDL apheresis [9]. However,
these therapies require special equipment and the
qualification of being an expert; thus, the availability
may be limited depending on the particular situation.
On the other hand, MDT can be conducted less prob-
lematically in ordinary hospitals or outpatient clinics.
Four debridement methods for selective removal of
necrotic tissues are: (1) surgical debridement,
(2) enzymatic debridement, (3) autolytic debridement
and (4) biological debridement (MDT). Of these, MDT
selectively and effectively debrides necrotic tissues, as
well as providing sterilising effects and the promotion
of granulation formation; thus, MDT should be consid-
ered one of the adjuvant treatment strategies for CLI
patients following revascularization of the limb [10].
To the best of our knowledge, there have been no
reports on iatrogenic skin ulcer induced by wound
dressing, though adverse effects of MDT have been
reported, including pain, dermatitis in the periphery of
wound, and ammonia-like odour. In clinical practice,
MDT is sometimes performed for patients with
Wound in paent with crical limb ischemia 
Convenonal therapy is ineﬀecve 
Absence of severe infecon
Yes
Infecon control
Choice of maggot therapy
• Outpaents
• Frequent lesion observaon is 
necessitated
Yes
No
Other treatment methods
Yes
Indirect method
(Contain maggots in a bag)
Peripheral skin is relavely in good 
condion (no fragility)
Direct method 
(with use of coang agent, release 
agent, and/or ultra-thin ﬁlm dressing 
on the peripheral skin)
or Indirect method
Direct method
Yes
No
Absence of signiﬁcant pain
No
Yes
Wound is located in non-joint area
No
Yes
No
No
Yes
Indirect method
Figure 4. Flow chart for selection of maggot debridement and dressing methods in our hospital.
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diabetes or CLI in whom the skin is fragile; thus, care-
ful management is necessary for such patients. Based
on our experience, we propose three cautions in
applying dressing during MDT for CLI patients: (1) avoid
placement of dressing in the joint motion range as far
as possible, (2) take into account the possibility of an
increase of skin pressure in the motion range after
dressing and (3) when the peripheral skin is fragile,
select an indirect method or very gently handle by
applying a coating agent, release agent, and/or ultra-
thin films. Based on the above considerations, we cre-
ated a flow chart in the selection of MDT dressing for
wounds of CLI patients as shown in Figure 4.
Conclusion
Although MDT is apparently effective for chronic skin
ulcer, cautions need to be taken for patients with CLI,
considering the fragility and infectiousness of the skin
surface at the time of dressing, especially at the joint
portion where pressure comes to bear when flexed.
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